NCT00382122

Brief Summary

Demographic information and a brief medical and concomitant medicine history will be obtained from the glaucoma patient's records. Qualified patients will be asked to complete a questionnaire about their symptoms. Patients will then be scheduled to undergo three standard clinical tests of the ocular surface.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2006

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2006

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

September 27, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 28, 2006

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2007

Completed
Last Updated

May 28, 2012

Status Verified

September 1, 2007

Enrollment Period

5 months

First QC Date

September 27, 2006

Last Update Submit

May 25, 2012

Conditions

Glaucoma

Keywords

GlaucomaOcular hypertensionDry eyeOcular surface disease

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients 18 years or older with open-angle glaucoma or ocular hypertension were consecutively recruited for the study.

You may qualify if:

  • Diagnosis of glaucoma;

You may not qualify if:

  • Inability to understand trial procedures;
  • Inability to understand Informed Consent;
  • Current use or use within the last 3 months of Restasis, steroids, or topical ocular non-steroidal anti-inflammatory drugs;
  • Punctal plugs;
  • Previous glaucoma, corneal, or conjunctival surgery;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

La Jolla

La Jolla, California, 92093, United States

Location

Related Publications (1)

  • Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma. 2008 Aug;17(5):350-5. doi: 10.1097/IJG.0b013e31815c5f4f.

    PMID: 18703943RESULT

MeSH Terms

Conditions

GlaucomaOcular HypertensionDry Eye Syndromes

Condition Hierarchy (Ancestors)

Eye DiseasesLacrimal Apparatus Diseases

Study Officials

  • Felipe Medeiros, MD, PhD

    University of California, San Diego

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 27, 2006

First Posted

September 28, 2006

Study Start

September 1, 2006

Primary Completion

February 1, 2007

Study Completion

February 1, 2007

Last Updated

May 28, 2012

Record last verified: 2007-09

Locations

US(1)